• Phalloidin (B7678): Technical Guide for F-Actin Stabilizatio

  2026-07-08

  Phalloidin (SKU B7678) is a cyclic heptapeptide toxin used for high-affinity stabilization and visualization of filamentous actin (F-actin) in fixed and permeabilized cell samples. It addresses the need for reproducible, species-independent cytoskeleton visualization in microscopy workflows. This reagent is unsuitable for live-cell imaging or studies requiring reversible actin dynamics.

• PD 0332991 (Palbociclib) HCl: Advanced Workflows in Cancer R

  2026-07-07

  Unlock robust G1 phase arrest and precision cell cycle analysis with PD 0332991 (Palbociclib) HCl. This guide delivers actionable protocols, troubleshooting strategies, and insights from cutting-edge research to empower translational oncology workflows.

• Lycium barbarum Polysaccharide Attenuates Sarcopenic Obesity

  2026-07-07

  This study demonstrates that Lycium barbarum polysaccharide (LBP) mitigates high-fat-diet-induced skeletal muscle atrophy by activating the AMPK/PINK1/Parkin mitophagy pathway. The findings reveal new mechanistic insights into mitochondrial quality control in sarcopenic obesity and highlight potential translational routes for metabolic disease research.

• Angiotensin (1-7): Translational Leverage from Mechanism to

  2026-07-06

  This thought-leadership article explores the unique mechanistic and translational potential of Angiotensin (1-7) (Asp-Arg-Val-Tyr-Ile-His-Pro), highlighting its value for researchers seeking to harness endogenous counter-regulation of pathological pathways. We merge insights from recent ACE2 activity studies, advanced protocol guidance, and the evolving landscape of cross-domain applications—including anti-fibrotic, metabolic, neuroprotective, and emerging antiviral research. Strategic recommendations and rigorously sourced protocol parameters empower translational scientists to maximize the impact of Angiotensin (1-7) using APExBIO’s high-purity peptide.

• Single-Molecule Imaging Reveals R-Loop Replication Collision

  2026-07-06

  This study directly visualizes how R-loops impede DNA replication using single-molecule fluorescence imaging and a minimal Phi29 DNA polymerase system. The findings clarify the molecular basis of replication fork stalling at R-loops, with implications for understanding genome stability and the development of advanced RNA labeling strategies.

• α-Bungarotoxin: Mechanistic Insights and Innovations in Chol

  2026-07-05

  Explore the molecular mechanism and advanced research applications of α-Bungarotoxin in nicotinic receptor blockade. This article delivers a unique, evidence-driven perspective on assay design and translational opportunities for neuroscience and placental models.

• Perospirone (SM-9018): Beyond Receptors in Translational Mod

  2026-07-04

  This thought-leadership article explores Perospirone (SM-9018 freebase) as more than an atypical antipsychotic, highlighting its dual activity on serotonergic/dopaminergic receptors and vascular ion channels. We synthesize new mechanistic findings, competitive context, and translational guidance for researchers modeling neuropsychiatric and cardiovascular comorbidity, demonstrating how APExBIO’s Perospirone uniquely advances experimental rigor.

• SM-102: Mechanistic Foundations and Strategic Horizons in mR

  2026-07-03

  Explore the advanced mechanistic insights and strategic imperatives surrounding SM-102 as a lipid nanoparticle component for mRNA vaccine development. This article provides translational researchers with a rigorous, evidence-based roadmap—bridging molecular design, comparative benchmarking, and real-world workflow optimization—to accelerate innovation in mRNA therapeutics.

• Tetracycline Hydrochloride: Mechanisms and Strategy in Trans

  2026-07-03

  This article delivers mechanistic insights and strategic guidance for translational researchers using Tetracycline Hydrochloride, blending the latest evidence on its role as a bacteriostatic antibiotic with practical recommendations for experimental design. It contextualizes Tetracycline Hydrochloride's activity against Staphylococcus aureus and Propionibacterium acnes, explores evidence-based protocols, and positions APExBIO's product as a benchmark for reproducible research. The discussion further distinguishes this thought-leadership piece by connecting mechanistic depth to clinical translation, while referencing emergent paradigms in antimicrobial research.

• Tunable Human Intestinal Organoids: Balancing Self-Renewal a

  2026-07-02

  This study presents a refined human intestinal organoid platform that achieves a controlled balance between stem cell self-renewal and differentiation through precise modulation of signaling pathways. The system enables enhanced cellular diversity and proliferative capacity under uniform conditions, with important implications for high-throughput disease modeling and regenerative research.

• Co-Targeting BRD4 and RAC1: Disrupting Oncogenic Pathways in

  2026-07-02

  This article reviews how combined inhibition of BET bromodomain BRD4 and RAC1 suppresses tumorigenesis, stemness, and growth in various breast cancer subtypes by targeting epigenetic and transcriptional regulators. The study unveils a mechanism that disrupts the c-MYC–G9a–FTH1 axis and downregulates HDAC1, providing new insight into epigenetic strategies for cancer therapy.

• Topotecan for Ovarian Cancer: Systematic Review Insights

  2026-07-01

  This article analyzes the clinical efficacy and safety of Topotecan in recurrent ovarian cancer, as systematically reviewed in a Cochrane meta-analysis. The findings clarify Topotecan’s role in standard and combination regimens, its comparative benefits and toxicities, and implications for translational cancer research.

• Pseudo-UTP: Pseudo-Modified Uridine Triphosphate for Stable

  2026-07-01

  Pseudo-modified uridine triphosphate (Pseudo-UTP) is a nucleoside triphosphate analogue that enables efficient incorporation of pseudouridine into RNA, enhancing RNA stability and reducing immunogenicity. This modification is pivotal for mRNA vaccine development and gene therapy, as validated by recent preclinical mRNA vaccine studies.

• Parathyroid hormone (1-34) (human): Precision in Bone and Ki

  2026-06-30

  Parathyroid hormone (1-34) (human) empowers high-fidelity modeling of calcium homeostasis, bone metabolism, and next-generation kidney assembloids. Discover optimized workflows, troubleshooting tips, and data-driven insights that set this PTH (1-34) peptide fragment apart for advanced experimental research.

• 3-Hydroxybutyrate: Bridging Metabolism and Epigenetics in Ne

  2026-06-30

  Explore how 3-hydroxybutyrate (BHBA) is redefining neuroprotection research. This article delivers a mechanistic and strategic guide for translational researchers, integrating the latest evidence on metabolic-epigenetic signaling, protocol optimization, and the future landscape for advanced stroke and neurodegeneration models.

451 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page